- Home
- SITE vs MIRM Comparison
SITE vs MIRM Comparison
Compare SITE & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SITE | MIRM |
|---|---|---|
| Founded | 2001 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional and commerical equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 5.7B |
| IPO Year | 2015 | 2019 |
Fundamental Metrics
Financial Performance| Metric | SITE | MIRM |
|---|---|---|
| Price | $135.40 | $95.28 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 12 |
| Target Price | ★ $157.14 | $115.33 |
| AVG Volume (30 Days) | 571.2K | ★ 828.1K |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 24.35 | ★ 74.59 |
| EPS | ★ 3.37 | N/A |
| Revenue | ★ $4,704,800,000.00 | $19,138,000.00 |
| Revenue This Year | $6.68 | $26.22 |
| Revenue Next Year | $4.28 | $22.04 |
| P/E Ratio | $39.86 | ★ N/A |
| Revenue Growth | ★ 3.62 | N/A |
| 52 Week Low | $106.74 | $37.83 |
| 52 Week High | $168.56 | $109.28 |
Technical Indicators
Market Signals| Indicator | SITE | MIRM |
|---|---|---|
| Relative Strength Index (RSI) | 51.62 | 50.50 |
| Support Level | $123.00 | $85.35 |
| Resistance Level | $138.50 | $96.65 |
| Average True Range (ATR) | 5.77 | 3.79 |
| MACD | 0.86 | 0.88 |
| Stochastic Oscillator | 62.32 | 60.83 |
Price Performance
Historical ComparisonAbout SITE SiteOne Landscape Supply Inc.
SiteOne Landscape Supply Inc is a supplier of tools and equipment. The company serves various businesses which include wholesale irrigation, outdoor lighting, nursery, landscape supplies, grass seeds, and fertilizers, turf protection products, turf care equipment, and golf course accessories for green industry professionals mainly in the United States and Canada. Its product portfolio includes irrigation supplies, fertilizer and herbicides, landscape accessories, nursery goods, natural stones and blocks, outdoor lighting and ice melt products and other products.
About MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.